EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Recombinant OMV-Based Vaccine Elicits Potent Protective Immunity Against Pseudomonas aeruginosa

Jiannan Li, Guangyu Qi, Mingyue Cao, Zixian Wang, Gejin Lu iD, Xulong Lang, Feng Wei, Tiancheng Lu, Lingwei Zhu iD, Xiuran Wang

Vaccines · 09.06.2026 · 14 (6) · 518

DOI: 10.3390/vaccines14060518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 09.06.2026. Verfasst von Jiannan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Jilin Agricultural University, Changchun 130118, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Natural Science Foundation of China, Jilin Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to construct a recombinant Pseudomonas aeruginosa outer membrane vesicle (OMV) vector vaccine delivering pcrV and compare the immunological impacts of OMVs as carriers versus as adjuvants.

Methods

The recombinant plasmid pBBRMCS5-pcrV was constructed and transformed into P. aeruginosa. Recombinant OMVs (OMVPcrV) were prepared via ultracentrifugation and characterized in terms of their morphology and particle size by means of transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). After a biosafety evaluation, mice were intramuscularly immunized with PcrV or OMVPcrV, followed by a booster immunization on day 21. On day 42, the mice were challenged subcutaneously and intranasally with PAO1. Bacterial loads in tissues and blood, pulmonary T-cell subsets, and serum antibody levels were assessed.

Results

The recombinant plasmid was successfully constructed, and Western blotting confirmed the delivery of PcrV into OMVs. TEM revealed typical spherical nanostructures, and NTA showed a median particle size of 127.4 ± 5.3 nm. Upon subcutaneous challenge, the OMV, OMVPcrV, and OMV + PcrV groups all achieved 100% protection. Both the OMVPcrV and OMV + PcrV groups exhibited increased CD4+ and CD8+ T-cell counts and higher induction levels of specific IgM, IgG1, and IgG2a antibodies. The OMVPcrV group showed superior clearance of respiratory bacterial colonization and reduced inflammatory injury compared with the PBS control group.

Conclusions

The constructed vector successfully delivered the PcrV antigen, and the OMVPcrV vaccine induced effective immune responses. Compared with wild-type outer membrane vesicles (OMVs) and the strategy of directly mixing free PcrV antigen with OMVs (OMV + PcrV), the recombinant OMVPcrV vaccine exhibited superior immunoprotective efficacy in terms of bacterial clearance and tissue protection, providing experimental evidence for the development of a Pseudomonas aeruginosa vaccine.

Schlagwörter

Stichwörter der Autor:innen

antigen deliveryimmunogenicityouter membrane vesiclesvaccine

Autor:innen und Institutionen

  • College of Life Sciences, Jilin Agricultural University, Changchun 130118, China.
  • Key Laboratory of Jilin Province for Zoonoses Prevention and Control, State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Changchun 130122, China.
  • School of Laboratory Animal & Shandong Laboratory Animal Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.

ORCID-Profile: Gejin Lu, Lingwei Zhu

Förderung

  • Jilin Provincial Natural Science Foundation of China
  • Jilin Provincial Department of Education

Zitieren

APA

Li, J., Qi, G., Cao, M., Wang, Z., Lu, G., Lang, X., Wei, F., Lu, T., Zhu, L., & Wang, X. (2026). A Recombinant OMV-Based Vaccine Elicits Potent Protective Immunity Against Pseudomonas aeruginosa. Vaccines, 14(6), 518. https://doi.org/10.3390/vaccines14060518

Vancouver

Li J, Qi G, Cao M, Wang Z, Lu G, Lang X, et al. A Recombinant OMV-Based Vaccine Elicits Potent Protective Immunity Against Pseudomonas aeruginosa. Vaccines. 2026;14(6):518. doi:10.3390/vaccines14060518

BibTeX
@article{Li2026,
  author = {Li, Jiannan and Qi, Guangyu and Cao, Mingyue and Wang, Zixian and Lu, Gejin and Lang, Xulong and Wei, Feng and Lu, Tiancheng and Zhu, Lingwei and Wang, Xiuran},
  title = {A Recombinant OMV-Based Vaccine Elicits Potent Protective Immunity Against Pseudomonas aeruginosa},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {518},
  doi = {10.3390/vaccines14060518}
}
Kostenlos starten →